Drug Costs Tripled Inflation

Spending on prescription medicines by public insurers rose a “considerable” 7.4 percent last year compared to 1.7 percent in 2017, a federal agency reported yesterday. The Patented Medicine Prices Review Board found only “limited savings” from use of generic drugs: “Notable growth in 2018 was primarily driven by increases in the patented medicine market.”

This content is for Blacklock’s Reporter members only. Please login to view this content. (Register here.)

Back to Top